Understanding Telehealth Prescribing: Pros, Cons and DEA Rules

Understanding Telehealth Prescribing: Pros, Cons and DEA Rules

Telehealth prescribing is top-of-mind among healthcare stakeholders as the industry waits with bated breath to see if the pandemic-era regulatory flexibilities will be extended beyond 2024.Telehealth-based prescribing offers quick and convenient access to lifesaving medications. Regulatory flexibilities enacted during the COVID-19 pandemic significantly expanded access to telehealth prescribing for numerous therapies, including buprenorphine, methadone, Adderall, ketamine and Tramadol.However, while many are eager to see the flexibilities extended, bad actors have shone a harsh light on the potential pitfalls of expanded telehealth prescribing.The federal government has yet to weigh in, making telehealth prescribing regulations one of the most closely watched legislative issues as the end of 2024 draws near.

Medigy Insights

As telehealth prescribing, particularly in the behavioral healthcare space, has soared, there have been instances of fraud, waste and abuse.Telemental health companies Cerebral and Done Health have come under fire in recent years for overprescribing controlled substances, including medications for attention-deficit/hyperactivity disorder (ADHD). In 2022, CVS Health and Walmart announced they would no longer fill prescriptions for controlled substances provided by either company.


Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2025 Netspective Foundation, Inc. All Rights Reserved.

Built on Jun 5, 2025 at 12:44pm